FRANCE – Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapeutics, and Institut Curie, France’s leading cancer center, have announced a new chapter in their strategic cancer research collaboration. Based…
Read MoreBiomunex and Institut Curie in new strategic collaboration for cancer treatment
